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727Abstracts
between treatment quality and patient satisfaction is open to
debate. Further investigations regarding the alternative “coping
strategies” beyond pharmacological treatment are needed.
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OBJECTIVES: Measuring different qualities of pain in an inter-
national study required the linguistic validation of the 9-item
Neuropathic Pain Scale (NPS) in 24 languages. The original scale
was developed in US English. A rigorous methodology was
required to ensure conceptual equivalence and cultural relevance
across different languages. METHODS: The translation process
was conducted by a specialist in each target country using the
following standardized methodology: 1) two forward transla-
tions by professional translators who were native speakers of the
target language and ﬂuent in English; 2) comparison and recon-
ciliation of the translations by the specialist in the target country
and the translators; 3) backward translation by a native English
speaker; 4) comparison of source and backward version; and 5)
comprehension test on three patients suffering from general pain
and two from neuropathic pain. RESULTS: Issues regarding the
instructions and the translation of certain expressions used to
describe the different aspects of pain emerged during the creation
of the individual language versions. Patient feedback allowed 
the instructions to be placed in a more relevant location on the
measure. For some of the pain descriptions and synonyms on the
original US English version of the NPS, country-speciﬁc substi-
tutes had to be identiﬁed. CONCLUSIONS: The 24-language
versions of the NPS were established according to a rigorous
translation methodology. The process aims to ensure conceptual
equivalence across different language versions to facilitate inter-
national comparison and pooling of data. Issues encountered
during the linguistic validation process support the advantage of
integrating international feedback on concepts and wording
before a questionnaire is ﬁnalized.
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OBJECTIVES: To determine the responsiveness of the Shuttle
Walking test (SWT) (a dimension speciﬁc outcome measure mea-
suring metres walked) compared to a disease speciﬁc measure
Oswestry Disability Index and two generic outcome measures
(SF-36 and EQ-5D). Although there are a number of studies
assessing the responsiveness of outcome measure in back pain,
no study has explored the responsiveness of the shuttle walking
test relative to other outcomes measures for patients with chronic
back pain. METHODS: The shuttle-walking test was adminis-
tered at a rehabilitation clinic. The Oswestry disability index, SF-
36 and EQ-5D were assessed by questionnaire at baseline and
12 months. Responsiveness was assessed using conventional
measures such as effect size, standardised response mean (SRM)
and receiver operating (ROC) curves. RESULTS: Mean ﬁgures
of each instrument suggest an improvement in outcomes over
time. The physical component of the SF-36 yielded the highest
effect size (1.65) and the ODI the highest SRM (1.23) in the
improved group. The lowest effect size and SRM for the
improved group was recorded on the mental component of 
the SF-36 at -0.20 and -0.18 respectively. The greater respon-
siveness in the ROC curves among the instruments was achieved
by the ODI and the SF-36 physical component. CONCLU-
SIONS: The results presented in this paper appear to demon-
strate that the ODI, EQ-5D and the SF-36 physical component
are more sensitive to change in patients with chronic low back
pain than the SWT. The large sample size and the consistency of
the different methods across the improved and non-improved
groups support the results achieved.
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OBJECTIVES: Irritable bowel syndrome (IBS), chronic venous
insufﬁciency disease (CVID), and peripheral arterial occlusive
disease (PAOD) are prevalent diseases in general practice (GP).
Their impact on QoL is often underestimated by clinicians. The
objective of the study was to compare patients’ and clinicians’
perception on pain and QoL using validated QoL questionnaires.
METHODS: A cross-sectional survey included patients with IBS
(n = 239), CIVD (n = 240) and PAOD (n = 68), recruited by
respectively 163, 120 and 61 GP’s. Patients completed a speciﬁc
QoL questionnaire according to their disease (FDDQL, CIVIQ
or CLAU-S), and scored their pain on a 10-cm VAS [0–10
(maximal pain)]. GP’s were asked to estimate the pain intensity
and the QoL of their patients. RESULTS: Pain perception is
underestimated by clinicians vs patients in IBS and CIVD (respec-
tively 3.0 ± 2.1 vs. 3.9 ± 2.5 and 3.0 ± 2.0 vs. 4.2 ± 2.5) and
overestimated in PAOD (4.3 ± 2.1 vs. 3.5 ± 2.0). Similarly, 
clinicians underestimate QoL impairment in most dimensions 
of the IBS questionnaire (i.e. diet, sleep, discomfort, coming,
control, stress), and in CIVD (global score 28 ± 19 vs. 39 ± 20
patients, 100 = worst QoL). Clinicians overestimate the impact
on QoL in PAOD (global score 54 ± 21 vs. 66 ± 23, 100 = best
QoL). Levels of correlations between PROs and clinicians-
reported outcomes are moderate (e.g. r = 0.47 for pain score and
r = 0.43 for QoL between CIVD patients and clinicians). Corre-
lations between PRO’s are also not perfect (e.g. r = 0.63 for pain
vs QoL in IBS patients). CONCLUSIONS: Clinicians’ and
patients’ perspectives although overlapping to some extent, are
not similar. Thus, perception of pain cannot be accurately
inferred from the clinician’s point of view. Similarly, patient’s per-
ception of pain cannot completely reﬂect the impact on QoL.
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OBJECTIVES: To describe the utilization pattern of narcotic
analgesics and estimate the incidence of suspected addiction
